Year: 2026
Type: article
Study design: Case Report
Abstract: Choroidal metastases are the most common intraocular malignancies and most frequently originate from breast cancer. They usually occur in the setting of advanced systemic disease and may lead to significant visual impairment. We report the case of a 60-year-old postmenopausal woman with hormone receptor-positive, HER2-negative metastatic breast cancer who developed bilateral symptomatic choroidal metastases during first-line treatment with palbociclib and anastrozole. Initial staging revealed pulmonary and bone metastases. After three months of treatment, the patient achieved an initial clinical and radiological partial response. Despite this favorable initial response, she subsequently developed progressive bilateral visual impairment secondary to choroidal metastases. Fundus examination, fluorescein angiography, and optical coherence tomography demonstrated bilateral choroidal metastases involving the posterior pole and macular region. Given the rapid systemic progression of the disease and deterioration in performance status, no local ocular treatment could be undertaken. The patient died one month after the diagnosis of bilateral choroidal metastases. This case highlights that choroidal metastatic progression may occur despite an initial clinical and radiological response to systemic therapy, emphasizing the heterogeneous biological behavior of metastatic breast cancer. New visual symptoms in patients with metastatic breast cancer should prompt immediate ophthalmologic evaluation to enable early diagnosis and appropriate multidisciplinary management, with the aim of preserving visual function whenever possible.
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7208809014
